Cargando…
Higher ETV5 Expression Associates With Poor 5-Florouracil-Based Adjuvant Therapy Response in Colon Cancer
Discovery of markers predictive for 5-Fluorouracil (5-FU)-based adjuvant chemotherapy (adjCTX) response in patients with locally advanced stage II and III colon cancer (CC) is necessary for precise identification of potential therapy responders. PEA3 subfamily of ETS transcription factors (ETV1, ETV...
Autor principal: | Giri, Anil K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917823/ https://www.ncbi.nlm.nih.gov/pubmed/33658938 http://dx.doi.org/10.3389/fphar.2020.620811 |
Ejemplares similares
-
Effect of lycopene as an adjuvant therapy with 5-florouracil in human colon cancer
por: Alhoshani, Norah M., et al.
Publicado: (2022) -
The synergistic antitumor effect of Huaier combined with 5-Florouracil in human cholangiocarcinoma cells
por: Fu, Zhaoyu, et al.
Publicado: (2019) -
Nonhomologous end joining key factor XLF enhances both 5-florouracil and oxaliplatin resistance in colorectal cancer
por: Liu, Zhuo, et al.
Publicado: (2019) -
Colon Cancer Cells Gene Expression Signature As Response to 5- Fluorouracil, Oxaliplatin, and Folinic Acid Treatment
por: Negrei, Carolina, et al.
Publicado: (2016) -
Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis
por: Lu, Benson, et al.
Publicado: (2009)